Gaudium IVF Promoter Group Declares No Share Encumbrance for FY26
Gaudium IVF promoter Dr. Manika Khanna declared no share encumbrance by promoters or persons acting in concert for FY26. The declaration is under SEBI (SAST) Regulations. A list of promoter and promoter group members is provided.
This is a standard regulatory filing for promoters and does not indicate any new developments or changes in shareholding structure that would significantly impact the company.
The announcement is a routine regulatory disclosure regarding share encumbrance and does not contain any information that positively or negatively impacts the company's financial performance or future prospects.
Gaudium IVF and Women Health Limited announced that Dr. Manika Khanna, a promoter, has declared that the promoter, promoter group, and any persons acting in concert have not made any encumbrance over the company's shares, directly or indirectly, during the financial year ended March 31, 2026.
This declaration is made in terms of Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The announcement also includes Annexure-I, which lists the members of the promoter and promoter group. These include Dr. Manika Khanna, Dr. Peeyush Khanna, Mr. Vishad Khanna, Dr. Gautam Anand, Dr. Rajinder Kumar Anand, Mrs. Malini Anand, Ms. Shobhini Khanna, Mrs. Sucharita Malhotra, Mrs. Ritambhara Dewan, MJs. EKK Hospitality Private Limited, MJs. EKK Global Private Limited, MJs. Gaudium Foundation, and MJs. Gaudium Signature Lab.
What to do with a filing like this
Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.